Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Jonathan and I will be your conference operator today.
Stay updated with breaking news from Rafael Bejar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good afternoon. My name is Jonathan and I will be your conference operator today.
Operator: Hello and thank you for standing by and welcome to Aptose Biosciences reports for the Fourth Quarter and Yearend 2022 Conference Call. At this time, all participants on a listen-only mode.
Investegate announcements from MDS Foundation, Inc. (963786), Molecular International Prognostic Scoring System Developed for Myelodysplastic Syndromes
Efficient, Accurate Risk Stratification Will Transform Patient CareYARDVILLE, N.J., June 12, 2022 (GLOBE NEWSWIRE) -- Today, the MDS Foundation announced the development of a new prognostic scoring system
Efficient, Accurate Risk Stratification Will Transform Patient Care...